CD274 and cancer: The variability in the number of copies of the PD-L1 gene, its polymorphisms, regulatory epigenetic mechanisms, especially microRNA expression in cancer cells, can have a big impact on the expression of PD-L1 protein, and thus on the effectiveness of immunotherapy in patients with various types of cancers (11–15).